Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections licensed in the UK — tirzepatide (Mounjaro) and semaglutide (Wegovy) — have been studied in large clinical trials and reviewed by the MHRA, NICE and the NHS. They carry real side effects, mostly gastrointestinal, which affect many users and are usually mild and temporary. Serious risks exist but are uncommon. For most adults who meet the clinical criteria, the medicines are considered safe to use under prescriber supervision. They are prescription-only, which means a qualified clinician must assess your full health picture before treatment starts, and that assessment is where safety begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Maybe a colleague at work has started one of these injections and you're wondering whether it's right for you. Or you've seen alarming social-media posts and aren't sure what to believe. Either way, the question is reasonable: these are medicines, and medicines carry risk.
The clinical picture for tirzepatide and semaglutide is detailed and well-documented. Tirzepatide was tested in the SURMOUNT programme, which enrolled thousands of adults across multiple trials. Semaglutide's STEP 1 trial ran for 68 weeks across a similarly large population. The NHS tirzepatide page and the NHS semaglutide page both list the known side effects clearly, drawing on the same datasets regulators used to grant UK licences.
The short version: these medicines are not free of side effects, and they are not suitable for everyone. But for adults who meet the clinical criteria and are supervised by a prescriber, the evidence supports their use as safe, in the same considered way any prescription medicine can be called safe. The prescriber's job is to weigh your individual health picture against the known risks. That is precisely why they require a prescription.
If you want to understand what supervised treatment actually involves, our treatment options page walks through how the process works.
The most common side effects of weight loss injections are gut-related. Nausea is the one most people mention first. Loose stools, constipation, indigestion, burping and fatigue also appear regularly in trial data, and injection-site reactions are possible. These effects tend to cluster in the first week or two after starting treatment or moving up a dose, then settle for most people.
That pattern is one reason the dosing schedule starts low. The initial dose exists to let your body adjust; it is not where the treatment's main effect comes from. Titration happens gradually, guided by your prescriber.
Rarer but more serious side effects include acute pancreatitis. The MHRA's Drug Safety Update of 29 January 2026 specifically highlighted this risk for GLP-1 medicines: severe, persistent stomach pain that spreads towards the back (with or without vomiting) needs prompt medical assessment, not a wait-and-see approach. Other signals to take seriously include symptoms of gallbladder problems, signs of dehydration from repeated vomiting or diarrhoea, and any allergic reaction.
There is more detail on the full side-effect profile in our guide to using weight loss injections safely, and if you are wondering whether weight loss injections are safe given your own circumstances, our dedicated page covers the key considerations on individual risk in detail.
Most side effects from weight loss injections are uncomfortable rather than dangerous. A few are not.
Get urgent medical help if you experience: severe abdominal pain that is persistent or radiates to the back; signs of a serious allergic reaction such as swelling of the face, lips or throat, difficulty breathing or a rapid heart rate; symptoms of acute dehydration after prolonged vomiting or diarrhoea, including very dark urine, dizziness on standing or not passing urine; or any new or worsening thoughts of self-harm.
Contact your prescriber or GP (not necessarily urgently, but promptly) for ongoing nausea that is stopping you eating normally, persistent constipation, or any symptom that concerns you between consultations.
You can also report any suspected side effect directly via the MHRA's Yellow Card scheme. That reporting system is how regulators track signals that emerge after a medicine reaches wider use, and it matters: the MHRA's ongoing monitoring of tirzepatide and semaglutide relies partly on patients and clinicians submitting these reports.
If you're unsure where your symptom sits, our support team is available seven days a week, and prescribers at nume (sorry, at nume) can advise through the aftercare pathway.
Clinical trial data covers medicines made and handled correctly. A pen bought from an unverified seller on social media is a different matter entirely.
The MHRA has documented serious harm from counterfeit weight-loss pens, including cases where fake pens contained insulin rather than the labelled medicine. In 2025, enforcement action uncovered roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million, including the first illicit UK manufacturing site producing counterfeit tirzepatide pens, raided in Northampton. The MHRA's guidance is clear: buy only from a pharmacy you can verify.
Checking is straightforward. Every legitimate UK online pharmacy is listed on the GPhC register; you can verify a pharmacy at pharmacyregulation.org/registers. Sellers offering these medicines without a prescription, with deeply discounted pricing or via social-media DMs are red flags. If you have come across a weight loss injection being promoted through an unverified channel and want to understand what a legitimately dispensed option actually looks like, our product page explains what a properly supplied treatment involves. A discount code for a prescription-only medicine from an unverified source is not a bargain, it is a warning sign.
Genuine safety comes from a genuine supply chain: licensed medicines, dispensed by a GPhC-registered pharmacy, following a clinical assessment by a real prescriber. That is the only combination that delivers the medicine the trials studied. Many people asking whether the new weight loss injections are safe are surprised to find that the supply chain question matters as much as the clinical data itself, a point our prescribers discuss as part of every consultation. Our prescribers also cover suitability and side effects during that process, and if you want to go deeper on whether it is safe to take injections for weight loss given your personal health history, our dedicated page works through the key factors before you commit to anything. You can also start your free consultation to speak with the team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.